Medtech Canada, in a statement reported by Cantech Letter on Nov. 3, 2026, said new 50% United States tariffs under Section 338 took effect on Oct. 30 and capture a significant share of Canada's medical technology exports. The industry association is urging zero-for-zero tariffs between the two countries.
A tariff aimed at exports still lands inside Canadian hospitals. Medical technology moves through integrated North American supply chains, and when trade in devices gets more expensive and less predictable, procurement teams feel it in lead times, availability and the risk carried on every critical item a facility cannot run without.
A tariff on devices becomes a planning problem for every hospital that buys them.
The defence is documentation and diversification: knowing which products are exposed, which suppliers sit behind them, and which qualified alternatives exist before a shortage forces the question. That sourcing discipline is central to how KSPACE TECHNOLOGIES handles hardware procurement and supply across medical and IT equipment alike.
The same exposure logic applies beyond medical devices. IT hardware, components and peripherals move through the same cross-border channels, so a tariff shock in one category is a prompt to review the whole sourcing map, not just the affected shelf.
Procurement leads should map tariff exposure on their most critical items now, qualify alternates while shelves are still stocked, and keep the paper trail that proves where every key product comes from.